TCR transgenic clone selection guided by immune receptor analysis and single-cell RNA expression of polyclonal responders
eLife · 2024
DOI: 10.7554/elife.98344 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Nincy Debeuf und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Single-Cell Analysis, CD8-Positive T-Lymphocytes. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, iBOF, Vlaams Instituut voor Biotechnologie.
Abstract (Originalsprache)
Since the precursor frequency of naive T cells is extremely low, investigating the early steps of antigen-specific T cell activation is challenging. To overcome this detection problem, adoptive transfer of a cohort of T cells purified from T cell receptor (TCR) transgenic donors has been extensively used but is not readily available for emerging pathogens. Constructing TCR transgenic mice from T cell hybridomas is a labor-intensive and sometimes erratic process, since the best clones are selected based on antigen-induced CD69 upregulation or IL-2 production in vitro, and TCR chains are polymerase chain reaction (PCR)-cloned into expression vectors. Here, we exploited the rapid advances in single-cell sequencing and TCR repertoire analysis to select the best clones without hybridoma selection, and generated CORSET8 mice ( COR ona S pike E pitope specific CD8 T cell), carrying a TCR specific for the Spike protein of SARS-CoV-2. Implementing newly created DALI software for TCR repertoire analysis in single-cell analysis enabled the rapid selection of the ideal responder CD8 T cell clone, based on antigen reactivity, proliferation, and immunophenotype in vivo. Identified TCR sequences were inserted as synthetic DNA into an expression vector and transgenic CORSET8 donor mice were created. After immunization with Spike/CpG-motifs, mRNA vaccination or SARS-CoV-2 infection, CORSET8 T cells strongly proliferated and showed signs of T cell activation. Thus, a combination of TCR repertoire analysis and scRNA immunophenotyping allowed rapid selection of antigen-specific TCR sequences that can be used to generate TCR transgenic mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.
- Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
- Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
- VIB Single Cell Core, VIB Center, Ghent, Belgium.
- Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.
- Department of Head and Skin, Ghent University, Ghent, Belgium.
ORCID-Profile: Nincy Debeuf, Bart N Lambrecht
Förderung
- Fonds Wetenschappelijk Onderzoek
- iBOF
- Vlaams Instituut voor Biotechnologie
Zitieren
APA
Debeuf, N., Lameire, S., Vanheerswynghels, M., Deckers, J., De Wolf, C., Toussaint, W., Verbeke, R., Verstaen, K., Hammad, H., Vanhee, S., & Lambrecht, B. N. (2024). TCR transgenic clone selection guided by immune receptor analysis and single-cell RNA expression of polyclonal responders. eLife. https://doi.org/10.7554/elife.98344
Vancouver
Debeuf N, Lameire S, Vanheerswynghels M, Deckers J, De Wolf C, Toussaint W, et al. TCR transgenic clone selection guided by immune receptor analysis and single-cell RNA expression of polyclonal responders. eLife. 2024. doi:10.7554/elife.98344
BibTeX
@article{Debeuf2024,
author = {Debeuf, Nincy and Lameire, Sahine and Vanheerswynghels, Manon and Deckers, Julie and De Wolf, Caroline and Toussaint, Wendy and Verbeke, Rein and Verstaen, Kevin and Hammad, Hamida and Vanhee, Stijn and Lambrecht, Bart N},
title = {TCR transgenic clone selection guided by immune receptor analysis and single-cell RNA expression of polyclonal responders},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.98344}
}
EUVIMED